𝔖 Bobbio Scriptorium
✦   LIBER   ✦

FASN and CD36 predict survival in rituximab-treated diffuse large B-cell lymphoma

✍ Scribed by Olga V. Danilova, Larry J. Dumont, Norman B. Levy…

Book ID
120960253
Publisher
Springer-Verlag
Year
2012
Tongue
English
Weight
492 KB
Volume
6
Category
Article
ISSN
1865-5785

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The therapeutic effect of rituximab on C
The therapeutic effect of rituximab on CD5-positive and CD5-negative diffuse large B-cell lymphoma
✍ Rie Hyo; Naoto Tomita; Kengo Takeuchi; Tomohiro Aoshima; Atsuko Fujita; Hideyuki 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

## Abstract The prognosis of diffuse large B‐cell lymphoma (DLBCL) has improved markedly in recent years of rituximab era. The prognosis of __de novo__ CD5‐positive DLBCL is reported to be poor, but the effect of rituximab on this type of lymphoma remains unclear. To investigate the effect of ritux